Drug allergy registry
Part of Immune system & allergy clinical trials.
This study builds a registry to collect information and samples from people who have had a drug allergy. It aims to better understand these reactions and improve diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older.
- You had an allergic reaction (like rash, hives, swelling, or a severe reaction) within 1 hour of taking a medication.
- You previously agreed to be in a related allergy registry and allowed your samples or data to be used for other research.
- You are willing to sign a consent form to join this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how certain immune cells (eosinophils) behave during severe drug reactions like DRESS and during milder drug rashes. It may help doctors understand what drives organ damage and improve how these reactions are managed.
This registry aims to collect information from people who already have a diagnosed food allergy. Joining may help researchers better understand food allergy patterns and needs.
This study creates a biorepository to collect and store samples (blood, nasal fluid, skin swabs) from people with allergies, asthma, sinus disorders, or immune dysregulation. It aims to better understand these conditions over time, which may help develop better treatments.
This study is a food allergy registry where you can share your experiences and information. It may help researchers better understand food allergies across different ages.
This study is a real-world registry that collects information from adults with atopic dermatitis (eczema) to track how newly started treatments work and how safe they are over time. It may help researchers and doctors better understand medication effects in everyday care.
This study is a long-term registry for adolescents and adults with atopic dermatitis (eczema) who are starting or switching to a systemic medication (a drug that works throughout the body). It will track how these treatments work in real life and how patients feel over time.
Hear when a new Drug Hypersensitivity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.